Cargando…
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer
INTRODUCTION: We developed an analytic strategy that correlates gene expression and clinical outcomes as a means to identify novel candidate oncogenes operative in breast cancer. This analysis, followed by functional characterization, resulted in the identification of Jumonji Domain Containing 6 (JM...
Autores principales: | Lee, Yi Fang, Miller, Lance David, Chan, Xiu Bin, Black, Michael A, Pang, Brendan, Ong, Chee Wee, Salto-Tellez, Manuel, Liu, Edison T, Desai, Kartiki V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446348/ https://www.ncbi.nlm.nih.gov/pubmed/22621393 http://dx.doi.org/10.1186/bcr3200 |
Ejemplares similares
-
Erratum to: JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer
por: Lee, Yi Fang, et al.
Publicado: (2017) -
Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer
por: Soon, Wendy WeiJia, et al.
Publicado: (2011) -
JMJD6 orchestrates a transcriptional program in favor of endocrine resistance in ER+ breast cancer cells
por: Das, Partha, et al.
Publicado: (2022) -
Both EZH2 and JMJD6 regulate cell cycle genes in breast cancer
por: Biswas, Antara, et al.
Publicado: (2020) -
JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma
por: Liu, Honggang, et al.
Publicado: (2023)